• Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-05-01

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) delivers unmatched dual-fluorescence tracking and translation efficiency in real-time, simplifying both nanoparticle optimization and innate immunity suppression research. APExBIO’s rigorously engineered capped, Cy5-labeled mRNA sets a new benchmark for quantitative gene delivery workflows and troubleshooting translational bottlenecks.

• (-)-JQ1 as a Precision Control: Dissecting BET Inhibition in

  2026-05-01

  Explore the distinct role of (-)-JQ1, the JQ1 stereoisomer, in epigenetics research and cancer biology. This in-depth article uniquely bridges practical assay design with mechanistic insight from recent advances in HPV-associated cancer studies.

• Rotenone (SKU B5462): Reliable Mitochondrial Complex I Inhib

  2026-04-30

  This article guides biomedical researchers through real-world laboratory challenges addressed by Rotenone (SKU B5462), a validated mitochondrial Complex I inhibitor from APExBIO. Scenario-driven Q&As detail experimental design, protocol optimization, data interpretation, and vendor selection—illustrating how SKU B5462 ensures reproducibility and robust results in cell viability, apoptosis, and autophagy pathway research.

• Strategic Apoptosis Analysis: Src/JNK, Corynoline & APExBIO

  2026-04-30

  This executive article bridges mechanistic understanding of mitochondrial apoptosis—illuminated by recent advances in osteosarcoma research—with best-practice guidance for translational researchers leveraging the Annexin V-FITC/7-AAD Apoptosis Kit. By contextualizing the Src/JNK pathway’s role in corynoline-induced apoptosis and providing protocol optimization strategies, this piece defines new standards for apoptosis and cell death analysis in oncology and drug development.

• KPT-330 (Selinexor): Applied Workflows & CRM1 Inhibition in

  2026-04-29

  KPT-330 (Selinexor) is revolutionizing cancer research by providing highly selective, orally bioavailable CRM1 inhibition, enabling robust apoptosis induction and tumor growth suppression in diverse cancer models. This article delivers stepwise experimental guidance, advanced protocol enhancements, and troubleshooting strategies to maximize assay success and translational impact with APExBIO's validated compound.

• Saquinavir: Precision HIV Protease Inhibitor for Research

  2026-04-29

  Saquinavir is a potent HIV protease inhibitor widely used in antiretroviral drug research. Its well-characterized mechanism, high purity, and compatibility with advanced permeability assays make it a benchmark tool for both HIV infection research and emerging cancer studies.

• DAPI (hydrochloride): Practical Parameters for DNA Visualiza

  2026-04-28

  DAPI (hydrochloride) is a fluorescent DNA-binding dye designed for robust staining in applications such as chromosome visualization, cell cycle analysis, and quantitative DNA assessment in both histochemistry and flow cytometry. It is not optimal for live cell imaging without protocol adjustments due to low membrane permeability and is unsuitable for RNA-specific detection.

• Calpeptin as a Calpain Inhibitor: Mechanistic Impact on Fibr

  2026-04-28

  Explore how Calpeptin, a potent calpain inhibitor, advances pulmonary fibrosis research with unmatched mechanistic precision. This article uniquely bridges molecular apoptosis control with fibrosis assay optimization for scientists seeking deeper insight.

• Dynasore: Technical Guide for Dynamin GTPase Inhibition

  2026-04-27

  Dynasore is a cell-permeable, reversible dynamin GTPase inhibitor widely used to block dynamin-dependent endocytosis and vesicle trafficking in cellular models. It is ideal for dissecting endocytic pathways and synaptic vesicle recycling but should not be used for long-term inhibition or in workflows requiring aqueous solubility. Researchers should carefully optimize solubilization and storage to maintain compound activity.

• Neurotensin: Precision Neurotensin Receptor 1 Activator for

  2026-04-27

  Neurotensin (CAS 39379-15-2) is a gold-standard tool for dissecting GPCR trafficking and miRNA regulation in gastrointestinal and neural systems. This guide delivers actionable workflows, troubleshooting strategies, and evidence-based optimizations for high-confidence results using APExBIO’s ultra-pure neurotensin peptide.

• Protein A/G Magnetic Co-IP/IP Kit: Unveiling Ubiquitin-Drive

  2026-04-26

  Explore how the Protein A/G Magnetic Co-IP/IP Kit empowers advanced co-immunoprecipitation of protein complexes, with a focus on dissecting ubiquitination in stem cell differentiation. This article reveals unique mechanistic insights and assay strategies not covered elsewhere.

• Berberrubine Chloride in Cancer & Metabolic Research Workflo

  2026-04-25

  Berberrubine chloride enables multi-pathway targeting in cancer and metabolic disease models, offering selective inhibition and reproducible workflow integration. Discover best-practice protocols, advanced troubleshooting, and unique reference-backed insights for maximizing research outcomes.

• ER-Targeted EISA Peptides Induce Selective Cancer Cell Death

  2026-04-24

  This study introduces an innovative peptide design that leverages enzyme-instructed self-assembly (EISA) to selectively accumulate on the endoplasmic reticulum (ER) in cancer cells, inducing ER stress and triggering apoptosis and necroptosis. The findings demonstrate that ER-targeted EISA overcomes prior concentration limitations and offers a promising strategy for efficient modulation of cancer cell fate.

• MVC Triggers RhoA/ROCK1/MLC2 Pathway to Disrupt Tight Juncti

  2026-04-24

  This study uncovers how the Minute Virus of Canines (MVC) activates the RhoA/ROCK1/MLC2 signaling cascade, leading to tight junction dissociation and facilitating Occludin-mediated viral entry. The work establishes a direct link between viral structural protein VP2 and host ROCK1, revealing new molecular targets for anti-MVC strategies.

• Gastrin I in Human Gastrointestinal Physiology Studies

  2026-04-23

  Gastrin I (human) from APExBIO empowers precise modeling of gastric acid secretion and CCK2 receptor signaling in advanced in vitro systems. This guide provides actionable workflows, protocol optimization, and troubleshooting strategies to maximize experimental success in gastrointestinal disorder research and pharmacokinetic studies.

15047 records 1/1004 page Next 12345 下5页 Last page